EA
ANIP icon

Emerald Advisers’s ANI Pharmaceuticals ANIP Stock Holding History

Emerald Advisers’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Hold
1,256
– – ﹤0.01% 216
2026
Q1 		$96.6K Hold
1,256
– – ﹤0.01% 224
2025
Q4 		$99.1K Hold
1,256
– – ﹤0.01% 224
2025
Q3 		$115K Hold
1,256
– – ﹤0.01% 234
2025
Q2 		$82K Buy
1,256
+1,012
+415% +$65.9K ﹤0.01% 227
2025
Q1 		$16.3K Hold
244
– – ﹤0.01% 238
2024
Q4 		$13.5K Hold
244
– – ﹤0.01% 250
2024
Q3 		$14.6K Hold
244
– – ﹤0.01% 243
2024
Q2 		$15.5K Hold
244
– – ﹤0.01% 243
2024
Q1 		$16.9K Hold
244
– – ﹤0.01% 239
2023
Q4 		$13.5K Sell
244
-174,033
-100% -$9.58M ﹤0.01% 237
2023
Q3 		$10.1M Buy
174,277
+1
+0% +$58 0.49% 89
2023
Q2 		$9.38M Sell
174,276
-199,130
-53% -$8.83M 0.41% 93
2023
Q1 		$14.8M Sell
373,406
-69,830
-16% -$2.94M 0.71% 66
2022
Q4 		$17.8M Sell
443,236
-13,512
-3% -$508K 0.86% 49
2022
Q3 		$14.7M Buy
456,748
+868
+0.2% +$29.7K 0.76% 56
2022
Q2 		$13.5M Buy
455,880
+101,835
+29% +$2.94M 0.7% 60
2022
Q1 		$9.95M Buy
354,045
+271,101
+327% +$10.1M 0.38% 97
2021
Q4 		$3.82M Buy
+82,944
New +$3.56M 0.14% 123
2014
Q4 		– Sell
-115,440
Closed -$3.27M – 340
2014
Q3 		$3.27M Buy
115,440
+2,150
+2% +$64.4K 0.19% 155
2014
Q2 		$3.9M Buy
113,290
+41,270
+57% +$1.29M 0.22% 147
2014
Q1 		$2.26M Buy
+72,020
New +$1.91M 0.13% 186

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Emerald Advisers's ANIP Position: Q2 2026 in Review

Emerald Advisers held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 1,256 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

Emerald Advisers first reported a position in ANIP in Q1 2014 and has held it in 22 quarters since. The position peaked at $17.8M in Q4 2022. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Emerald Advisers held 1,256 shares of ANI Pharmaceuticals worth $104K as of Q2 2026.
  • Emerald Advisers left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Emerald Advisers's portfolio in Q2 2026, its #216 holding.
  • Emerald Advisers first reported a position in ANI Pharmaceuticals in Q1 2014 and has held it in 22 quarters since.
  • Emerald Advisers's ANI Pharmaceuticals position peaked at $17.8M in Q4 2022.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.